AmphetamineAmphetaminesCentral Nervous System StimulantsDextroamphetamineAmphetamine-Related DisordersMethamphetamineSubstance Abuse DetectionN-Methyl-3,4-methylenedioxyamphetamineDopamineStereotyped Behavior3,4-MethylenedioxyamphetamineMotor ActivityNucleus AccumbensDopamine AgentsBehavior, AnimalGas Chromatography-Mass SpectrometryDopamine Uptake InhibitorsTime FactorsStreet DrugsDesigner DrugsAppetite DepressantsRats, Sprague-DawleyCocaineDopamine Plasma Membrane Transport ProteinsCorpus StriatumDose-Response Relationship, DrugHallucinogensEnzyme Multiplied Immunoassay TechniqueForensic MedicineMethylphenidateDopamine Agonistsp-ChloroamphetamineLong-Term CareAdrenergic Uptake InhibitorsMethyltyrosinesFollow-Up StudiesNeostriatumMicrodialysisDopamine AntagonistsPhenmetrazineReceptors, Dopamine D2NomifensinePyrazolonesEphedrineFenfluraminePsychoses, Substance-InducedConditioning, OperantBenzphetamineSubstance Withdrawal SyndromeSubstance-Related DisordersRewardAnalysis of VarianceApomorphineDrug InteractionsTreatment OutcomeCaudate NucleusHyperkinesisVentral Tegmental AreaPhenethylaminesSerotonin AgentsSerotoninRats, Long-Evansalpha-MethyltyrosineTerm BirthReceptors, Biogenic AmineSelf AdministrationBrainPhenylpropanolamineRacloprideLocomotionBarbituratesAdrenergic AgentsPsychotropic DrugsHairReserpinePargylineChlorfenvinphosStartle ReactionFluorescence Polarization ImmunoassaySelegilineSpecific GravityInjections, IntraperitonealReceptors, DopamineSympathomimeticsReceptors, Dopamine D1QuinpiroleTyramineStereoisomerismExploratory BehaviorBiogenic MonoaminesConditioning (Psychology)NarcolepsyConditioning, ClassicalMonoamine Oxidase InhibitorsImmunoassayRats, WistarPhencyclidineSalicylamidesReinforcement ScheduleEuphoria